UAB Biotechnology The University of Alabama at Birmingham's Master of Science in Biotechnology Program is designed to train you for a career in a sector that is adding new job... By: UABSHP … Continue reading →

SAARC member countries participate in South Asian Biotechnology Conference in New Delhi SAARC member countries participate in a 3-day long South Asian Biotechnology Conference in capital New Delhi. Organised by the South Asia University (SAU),... By: MEA India File … Continue reading →

19.02.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------- Cytos Biotechnology Ltd. invites for an Extraordinary Shareholders' Meeting Schlieren (Zurich), Switzerland, February 19, 2015 - Cytos Biotechnology Ltd ("Cytos" or "the Company"), announced today that an Extraordinary Shareholders' Meeting will take place on Monday, March 16, 2015 at 10 a.m. at Cytos' offices in Schlieren/Zurich (Switzerland). At this meeting, shareholders will be invited to approve the share capital increase which is needed to create the shares for the conversion of the convertible bonds into equity. Further, the conditional and authorized capital shall be amended. The formal invitation to the meeting will be sent out within the next few days and can also be downloaded on the following website: http://www.cytos.com/uploads/2015/EGM2015.pdf For further information, please contact: Cytos Biotechnology Ltd Harry Welten, MBA Chief Financial Officer Tel: +41 44 733 46 46 harry.welten@cytos.com About Cytos Biotechnology Ltd Continued here: EQS-Adhoc: Cytos Biotechnology AG: Invitation for an Extraordinary Shareholders' Meeting … Continue reading →